We are so proud to have been awarded a 2023 #RAREisGlobalAdvocateGrant by Horizon Therapeutics RAREis Program which recognizes our contributions to advancing, educating and addressing the needs of the rare disease community. We look forward to continuing to make a meaningful difference for those living with osteogenesis imperfecta (OI).